Population structure of the dengue viruses, Aragua, Venezuela, 2006-2007. Insights into dengue evolution under hyperendemic transmission

Infection, Genetics and Evolution

Volumn 12, Issue 2, 2012, Pages 332-344

  Rodriguez Roche, Rosmari ^a   Villegas, Elci ^b   Cook, Shelley ^c   Poh Kim, Pauline A W ^d   Hinojosa, Yoandri ^a   Rosario, Delfina ^a   Villalobos, Iris ^e   Bendezu, Herminia ^b   Hibberd, Martin L ^d   Guzman, Maria G ^a  

^a INSTITUTO DE MEDICINA TROPICAL PEDRO KOURÍ   (Cuba)

^b UNIVERSIDAD DE LOS ANDES   (Venezuela)

^c DEPARTMENT OF LIFE SCIENCES   (United Kingdom)

^d GENOME INSTITUTE OF SINGAPORE   (Singapore)

^e UNIVERSIDAD DE CARABOBO   (Venezuela)

Author keywords

Dengue; Evolution; Phylogeny; Venezuela

Indexed keywords

NONSTRUCTURAL PROTEIN 1; NONSTRUCTURAL PROTEIN 2; NONSTRUCTURAL PROTEIN 2A; NONSTRUCTURAL PROTEIN 4B; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; ARTICLE; CHILD; CONTROLLED STUDY; DENGUE VIRUS 1; DENGUE VIRUS 2; DENGUE VIRUS 3; DENGUE VIRUS 4; DISEASE TRANSMISSION; GENETIC VARIABILITY; GENOTYPE; HUMAN; MOLECULAR EPIDEMIOLOGY; MOLECULAR EVOLUTION; NONHUMAN; NUCLEOTIDE SEQUENCE; PHYLOGENETIC TREE; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEIN FUNCTION; SCHOOL CHILD; VENEZUELA; VIRUS GENOME; VIRUS ISOLATION;

DENGUE; DENGUE VIRUS; EVOLUTION, MOLECULAR; GENETIC VARIATION; HUMANS; MOLECULAR SEQUENCE DATA; PHYLOGENY; POPULATION; RNA, VIRAL; SEQUENCE ANALYSIS, DNA; VENEZUELA; VIRAL PROTEINS;

DENGUE VIRUS GROUP;

EID: 84857640632     PISSN: 15671348     EISSN: 15677257     Source Type: Journal    
DOI: 10.1016/j.meegid.2011.12.005     Document Type: Article

References (83)

1. Alexander, N., Balmaseda, A., Coelho, I.C., Dimaano, E., Hien, T.T., Hung, N.T., Janisch, T., Kroeger, A., Lum, L.C., Martinez, E., Siqueira, J.B., Thuy, T.T., Villalobos, I., Villegas, E., Wills, B., (2011). Multicentre prospective study on dengue classification in four South-east Asian and three Latin American countries. Trop. Med. Int. Health doi:. doi:10.1111/j.1365-3156.2011.02793.x.
2. Alvarez M., Rodriguez-Roche R., Bernardo L., Vazquez S., Morier L., Gonzalez D., Castro O., Kouri G., Halstead S.B., Guzman M.G. Dengue hemorrhagic fever caused by sequential dengue 1-3 virus infections over a long time interval: Havana epidemic, 2001-2002. Am. J. Trop. Med. Hyg. 2006, 75(6):1113-1117.
3. Bennett S.N., Holmes E.C., Chirivella M., Rodriguez D.M., Beltran M., Vorndam V., Gubler D.J., McMillan W.O. Selection-driven evolution of emergent dengue virus. Mol. Biol. Evol. 2003, 20(10):1650-1658.
4. Betts M.J., Russell R.B. Amino acid properties and consequences of substitutions. Bioinformatics for Geneticists 2003, 289-316. Wiley, New Jersey. M.R. Barnes, I.C. Gray (Eds.).
5. Brault A.C., Kinney R.M., Maharaj P.D., Green E.N., Reisen W.K., Huang C.Y. Replication of the primary dog kidney-53 dengue 2 virus vaccine candidate in Aedes aegypti is modulated by a mutation in the 5' untranslated region and amino acid substitutions in nonstructural proteins 1 and 3. Vector Borne Zoonotic. Dis. 2011, 11(6):683-689.
6. Brien J.D., Austin S.K., Sukupolvi-Petty S., O'Brien K.M., Johnson S., Fremont D.H., Diamond M.S. Genotype-specific neutralization and protection by antibodies against dengue virus type 3. J. Virol. 2010, 84(20):10630-10643.
7. Chambers T.J., McCourt D.W., Rice C.M. Yellow fever virus proteins NS2A, NS2B, and NS4B: identification and partial N-terminal amino acid sequence analysis. Virology 1989, 169(1):100-109.
8. Chen H.L., Lin S.R., Liu H.F., King C.C., Hsieh S.C., Wang W.K. Evolution of dengue virus type 2 during two consecutive outbreaks with an increase in severity in southern Taiwan in 2001-2002. Am. J. Trop. Med. Hyg. 2008, 79(4):495-505.
9. Chen M.C., Lin C.F., Lei H.Y., Lin S.C., Liu H.S., Yeh T.M., Anderson R., Lin Y.S. Deletion of the C-terminal region of dengue virus nonstructural protein 1 (NS1) abolishes anti-NS1-mediated platelet dysfunction and bleeding tendency. J. Immunol. 2009, 183(3):1797-1803.
10. Christenbury J.G., Aw P.P., Ong S.H., Schreiber M.J., Chow A., Gubler D.J., Vasudevan S.G., Ooi E.E., Hibberd M.L. A method for full genome sequencing of all four serotypes of the dengue virus. J. Virol. Methods 2010, 169(1):202-206.
11. Drummond A.J., Rambaut A. BEAST: Bayesian evolutionary analysis by sampling trees. BMC Evol. Biol. 2007, 7:214.
12. Garcia G., Sierra B., Perez A.B., Aguirre E., Rosado I., Gonzalez N., Izquierdo A., Pupo M., Danay Diaz D.R., Sanchez L., Marcheco B., Hirayama K., Guzman M.G. Asymptomatic Dengue infection in a Cuban population confirms the protective role of the RR variant of the FcgammaRIIa polymorphism. Am. J. Trop. Med. Hyg. 2010, 82(6):1153-1156.
13. Goncalvez A.P., Escalante A.A., Pujol F.H., Ludert J.E., Tovar D., Salas R.A., Liprandi F. Diversity and evolution of the envelope gene of dengue virus type 1. Virology 2002, 303(1):110-119.
14. Grant D., Tan G.K., Qing M., Ng J.K., Yip A., Zou G., Xie X., Yuan Z., Schreiber M.J., Schul W., Shi P.Y., Alonso S. A single amino acid in nonstructural protein NS4B confers virulence to dengue virus in AG129 mice through enhancement of viral RNA synthesis. J. Virol. 2011, 85(15):7775-7787.
15. Gubler D.J. The emergence of dengue/dengue haemorrhagic fever as a global public health problem. Factors in the Emergence of Arbovirus Diseases 1997, 83-92. Elsevier, Paris. J.F. Saluzzo, B. Dodet (Eds.).
16. Gubler D.J., Meltzer M. Impact of dengue/dengue hemorrhagic fever on the developing world. Adv. Virus Res. 1999, 53:35-70.
17. Guzman M.G. Dengue type 3 infection-Nicaragua and Panama October-November, 1994. MMWR 1995, 44:21-24.
18. Guzman M.G. Global voices of science. Deciphering dengue: the Cuban experience. Science 2005, 309(5740):1495-1497.
19. Guzman M.G., Deubel V., Pelegrino J.L., Rosario D., Marrero M., Sariol C., Kouri G. Partial nucleotide and amino acid sequences of the envelope and the envelope/nonstructural protein-1 gene junction of four dengue-2 virus strains isolated during the 1981 Cuban epidemic. Am. J. Trop. Med. Hyg. 1995, 52(3):241-246.
20. Guzman M.G., Kouri G. Dengue haemorrhagic fever integral hypothesis: confirming observations, 1987-2007. Trans. R. Soc. Trop. Med. Hyg. 2008, 102(6):522-523.
21. Guzman M.G., Kouri G., Bravo J., Valdes L., Vazquez S., Halstead S.B. Effect of age on outcome of secondary dengue 2 infections. Int. J. Infect. Dis. 2002, 6(2):118-124.
22. Guzman M.G., Kouri G., Valdes L., Bravo J., Alvarez M., Vazques S., Delgado I., Halstead S.B. Epidemiologic studies on Dengue in Santiago de Cuba, 1997. Am. J. Epidemiol. 1997, 152(9):793-799.
23. Guzman M.G., Kouri G., Valdes L., Bravo J., Vazquez S., Halstead S.B. Enhanced severity of secondary dengue-2 infections: death rates in 1981 and 1997 Cuban outbreaks. Rev. Panam. Salud Publica 2002, 11(4):223-227.
24. Guzman M.G., Vazquez S., Martinez E., Alvarez M., Rodriguez R., Kouri G., De Los Reyes J., Acevedo F. Dengue in Nicaragua, 1994: reintroduction of serotype 3 in the Americas. Rev. Panam. Salud Publica 1997, 1(3):193-199.
25. Hanley K.A., Manlucu L.R., Gilmore L.E., Blaney J.E., Hanson C.T., Murphy B.R., Whitehead S.S. A trade-off in replication in mosquito versus mammalian systems conferred by a point mutation in the NS4B protein of dengue virus type 4. Virology 2003, 312(1):222-232.
26. Henchal E.A., McCown J.M., Seguin M.C., Gentry M.K., Brandt W.E. Rapid identification of dengue virus isolates by using monoclonal antibodies in an indirect immunofluorescence assay. Am. J. Trop. Med. Hyg. 1983, 32(1):164-169.
27. Holmes E.C. RNA virus genomics: a world of possibilities. J. Clin. Invest. 2009, 119(9):2488-2495.
28. Huelsenbeck J.P., Ronquist F. MRBAYES: bayesian inference of phylogenetic trees. Bioinformatics 2001, 17(8):754-755.
29. Kelly E.P., Puri B., Sun W., Falgout B. Identification of mutations in a candidate dengue 4 vaccine strain 341750 PDK20 and construction of a full-length cDNA clone of the PDK20 vaccine candidate. Vaccine 2009, 28(17):3030-3037.
30. Klungthong C., Zhang C., Mammen M.P., Ubol S., Holmes E.C. The molecular epidemiology of dengue virus serotype 4 in Bangkok, Thailand. Virology 2004, 329(1):168-179.
31. Kouri G., Guzman M.G., Bravo J. Hemorrhagic dengue in Cuba: history of an epidemic. Bull. Pan. Am. Health Organ. 1986, 20(1):24-30.
32. Kouri G., Guzman M.G., Valdes L., Carbonel I., del Rosario D., Vazquez S., Laferte J., Delgado J., Cabrera M.V. Reemergence of dengue in Cuba: a 1997 epidemic in Santiago de Cuba. Emerg. Infect. Dis. 1998, 4(1):89-92.
33. Kouri G.P., Guzman M.G., Bravo J.R. Why dengue haemorrhagic fever in Cuba? 2. An integral analysis. Trans. R. Soc. Trop. Med. Hyg. 1987, 81(5):821-823.
34. Kummerer B.M., Rice C.M. Mutations in the yellow fever virus nonstructural protein NS2A selectively block production of infectious particles. J. Virol. 2002, 76(10):4773-4784.
35. Lanciotti R.S., Calisher C.H., Gubler D.J., Chang G.J., Vorndam A.V. Rapid detection and typing of dengue viruses from clinical samples by using reverse transcriptase-polymerase chain reaction. J. Clin. Microbiol. 1992, 30(3):545-551.
36. Lanciotti R.S., Gubler D.J., Trent D.W. Molecular evolution and phylogeny of dengue-4 viruses. J. Gen. Virol. 1997, 78(Pt 9):2279-2284.
37. Laue T., Emmerich P., Schmitz H. Detection of dengue virus RNA in patients after primary or secondary dengue infection by using the TaqMan automated amplification system. J. Clin. Microbiol. 1999, 37(8):2543-2547.
38. Leung J.Y., Pijlman G.P., Kondratieva N., Hyde J., Mackenzie J.M., Khromykh A.A. The role of nonstructural protein Ns2a in flavivirus assembly. J. Virol. 2008, 82(10):4731-4741.
39. Lindenbach B.D., Rice C.M. Trans-Complementation of yellow fever virus NS1 reveals a role in early RNA replication. J. Virol. 1997, 71(12):9608-9617.
40. Liu W.J., Chen H.B., Khromykh A.A. Molecular and functional analyses of Kunjin virus infectious cDNA clones demonstrate the essential roles for NS2A in virus assembly and for a nonconservative residue in NS3 in RNA replication. J. Virol. 2003, 77(14):7804-7813.
41. Liu W.J., Chen H.B., Wang X.J., Huang H., Khromykh A.A. Analysis of adaptive mutations in Kunjin virus replicon RNA reveals a novel role for the flavivirus nonstructural protein NS2A in inhibition of beta interferon promoter-driven transcription. J. Virol. 2004, 78(22):12225-12235.
42. Liu W.J., Wang X.J., Clark D.C., Lobigs M., Hall R.A., Khromykh A.A. A single amino acid substitution in the West Nile virus nonstructural protein NS2A disables its ability to inhibit alpha/beta interferon induction and attenuates virus virulence in mice. J. Virol. 2006, 80(5):2396-2404.
43. Liu W.J., Wang X.J., Mokhonov V.V., Shi P.Y., Randall R., Khromykh A.A. Inhibition of interferon signaling by the New York 99 strain and Kunjin subtype of West Nile virus involves blockage of STAT1 and STAT2 activation by nonstructural proteins. J. Virol. 2005, 79(3):1934-1942.
44. Mackenzie J.M., Jones M.K., Young P.R. Immunolocalization of the dengue virus nonstructural glycoprotein NS1 suggests a role in viral RNA replication. Virology 1996, 220(1):232-240.
45. Mackenzie J.M., Khromykh A.A., Jones M.K., Westaway E.G. Subcellular localization and some biochemical properties of the flavivirus Kunjin nonstructural proteins NS2A and NS4A. Virology 1998, 245(2):203-215.
46. Mathew A., Rothman A.L. Understanding the contribution of cellular immunity to dengue disease pathogenesis. Immunol. Rev. 2008, 225:300-313.
47. McElroy K.L., Tsetsarkin K.A., Vanlandingham D.L., Higgs S. Manipulation of the yellow fever virus non-structural genes 2A and 4B and the 3'non-coding region to evaluate genetic determinants of viral dissemination from the Aedes aegypti midgut. Am. J. Trop. Med. Hyg. 2006, 75(6):1158-1164.
48. Munoz-Jordan J.L., Sanchez-Burgos G.G., Laurent-Rolle M., Garcia-Sastre A. Inhibition of interferon signaling by dengue virus. Proc. Natl. Acad. Sci. USA 2003, 100(24):14333-14338.
49. Muylaert I.R., Galler R., Rice C.M. Genetic analysis of the yellow fever virus NS1 protein: identification of a temperature-sensitive mutation which blocks RNA accumulation. J. Virol. 1997, 71(1):291-298.
50. PAHO (1979). Dengue in the Caribbean, 1977. Proceedings of a Workshop held in Montego Bay, Jamaica, 8-11 May, 1978. PAHO Scientific Publication 375.
51. PAHO (1990). Dengue hemorrhagic fever in Venezuela. Epidemiol. Bull. 11, 7-9.
52. Park G.S., Morris K.L., Hallett R.G., Bloom M.E., Best S.M. Identification of residues critical for the interferon antagonist function of Langat virus NS5 reveals a role for the RNA-dependent RNA polymerase domain. J. Virol. 2007, 81(13):6936-6946.
53. Posada D., Crandall K.A. MODELTEST: testing the model of DNA substitution. Bioinformatics 1998, 14(9):817-818.
54. Ramirez A., Fajardo A., Moros Z., Gerder M., Caraballo G., Camacho D., Comach G., Alarcon V., Zambrano J., Hernandez R., Moratorio G., Cristina J., Liprandi F. Evolution of dengue virus type 3 genotype III in Venezuela: diversification, rates and population dynamics. Virol. J. 2010, 7:329.
55. Rey F.A., Heinz F.X., Mandl C., Kunz C., Harrison S.C. The envelope glycoprotein from tick-borne encephalitis virus at 2 A resolution. Nature 1995, 375(6529):291-298.
56. Rodriguez-Roche R., Alvarez M., Gritsun T., Halstead S., Kouri G., Gould E.A., Guzman M.G. Virus evolution during a severe dengue epidemic in Cuba, 1997. Virology 1997, 334(2):154-159.
57. Rodriguez-Roche R., Alvarez M., Guzman M.G., Morier L., Kouri G. Comparison of rapid centrifugation assay with conventional tissue culture method for isolation of dengue 2 virus in C6/36-HT cells. J. Clin. Microbiol. 2000, 38(9):3508-3510.
58. Rodriguez-Roche R., Alvarez M., Holmes E.C., Bernardo L., Kouri G., Gould E.A., Halstead S., Guzman M.G. Dengue virus type 3, Cuba, 2000-2002. Emerg. Infect. Dis. 2005, 11(5):773-774.
59. Rodriguez-Roche R., Sanchez L., Burgher Y., Rosario D., Alvarez M., Kouri G., Halstead S.B., Gould E.A., Guzman M.G. Virus role during intraepidemic increase in dengue disease severity. Vector Borne Zoonotic. Dis. 2011, 11:675-681.
60. Salas R.A., Tovar D., Barreto A., de Miller E., Leitmeyer K., Rico-Hesse R. Serotypes and genotypes of dengue virus circulating in Venezuela, 1990-1997. Acta Cient. Venez. 1998, 49(Suppl. 1):33-37.
61. San Martin J.L., Brathwaite O., Zambrano B., Solorzano J.O., Bouckenooghe A., Dayan G.H., Guzman M.G. The epidemiology of dengue in the Americas over the last three decades: a worrisome reality. Am. J. Trop. Med. Hyg. 2010, 82(1):128-135.
62. Sangkawibha N., Rojanasuphot S., Ahandrik S., Viriyapongse S., Jatanasen S., Salitul V., Phanthumachinda B., Halstead S.B. Risk factors in dengue shock syndrome: a prospective epidemiologic study in Rayong, Thailand. I. The 1980 outbreak. Am. J. Epidemiol. 1980, 120(5):653-669.
63. Schmidt, D.J., Pickett, B.E., Camacho, D., Comach, G., Xhaja, K., Lennon, N.J., Rizzolo, K., de Bosch, N., Becerra, A., Nogueira, M.L., Mondini, A., da Silva, E.V., Vasconcelos, P.F., Munoz-Jordan, J.L., Santiago, G.A., Ocazionez, R., Gehrke, L., Lefkowitz, E.J., Birren, B.W., Henn, M.R., Bosch, I., (2011). A phylogenetic analysis using full-length viral genomes of South American dengue serotype 3 in consecutive Venezuelan outbreaks reveals a novel NS5 mutation. Infect Genet Evol. 11(8), 2011-2019.
64. Schreiber M.J., Holmes E.C., Ong S.H., Soh H.S., Liu W., Tanner L., Aw P.P., Tan H.C., Ng L.C., Leo Y.S., Low J.G., Ong A., Ooi E.E., Vasudevan S.G., Hibberd M.L. Genomic epidemiology of a dengue virus epidemic in urban Singapore. J. Virol. 2009, 83(9):4163-4173.
65. Seijo A. Dengue 2009: chronology of an epidemic. Arch. Argent. Pediatr. 2009, 107(5):387-389.
66. Sierra B., Alegre R., Perez A.B., Garcia G., Sturn-Ramirez K., Obasanjo O., Aguirre E., Alvarez M., Rodriguez-Roche R., Valdes L., Kanki P., Guzman M.G. HLA-A, -B, -C, and -DRB1 allele frequencies in Cuban individuals with antecedents of dengue 2 disease: Advantages of the Cuban population for HLA studies of dengue virus infection. Hum. Immunol. 2007, 68(6):531-540.
67. Sierra, B.D.L.C., Garcia, G., Perez, A.B., Morier, L., Alvarez, M., Kouri, G., and Guzman, M. G. (2006). Ethnicity and difference in dengue virus-specific memory T cell responses in Cuban individuals. Viral Immunol. 19(4), 662-668.
68. Steel A., Gubler D.J., Bennett S.N. Natural attenuation of dengue virus type-2 after a series of island outbreaks: a retrospective phylogenetic study of events in the South Pacific three decades ago. Virology 2010, 405(2):505-512.
69. Swofford D.L. PAUP*: Phylogenetic Analysis Using Parsimony (*and Other Methods) 2003, Sinauer Associates, Sunderland, Massachusetts.
70. Tajima S., Takasaki T., Kurane I. Restoration of replication-defective dengue type 1 virus bearing mutations in the N-terminal cytoplasmic portion of NS4A by additional mutations in NS4B. Arch. Virol. 2011, 156(1):63-69.
71. Tan G.K., Alonso S. Pathogenesis and prevention of dengue virus infection: state-of-the-art. Curr. Opin. Infect. Dis. 2009, 22(3):302-308.
72. Tang Y., Rodpradit P., Chinnawirotpisan P., Mammen M.P.Jr., Li T., Lynch J.A., Putnak R., Zhang C. Comparative analysis of full-length genomic sequences of 10 dengue serotype 1 viruses associated with different genotypes, epidemics, and disease severity isolated in Thailand over 22 years. Am. J. Trop. Med. Hyg. 2010, 83(5):1156-1165.
73. Thompson J.D., Gibson T.J., Plewniak F., Jeanmougin F., Higgins D.G. The ClustalX windows interface. Flexible strategies for multiple sequence alignment aided by quality analysis tools. Nucleic Acids Res. 1997, 24:4876-4882.
74. Twiddy S.S., Farrar J.J., Vinh Chau N., Wills B., Gould E.A., Gritsun T., Lloyd G., Holmes E.C. Phylogenetic relationships and differential selection pressures among genotypes of dengue-2 virus. Virology 2002, 298(1):63-72.
75. Uzcategui N.Y., Camacho D., Comach G., Cuello de Uzcategui R., Holmes E.C., Gould E.A. Molecular epidemiology of dengue type 2 virus in Venezuela: evidence for in situ virus evolution and recombination. J. Gen. Virol. 2001, 82:2945-2953.
76. Uzcategui N.Y., Comach G., Camacho D., Salcedo M., Cabello de Quintana M., Jimenez M., Sierra G., Cuello de Uzcategui R., James W.S., Turner S., Holmes E.C., Gould E.A. Molecular epidemiology of dengue virus type 3 in Venezuela. J. Gen. Virol. 2003, 84(Pt 6):1569-1575.
77. Vaughn D.W., Green S., Kalayanarooj S., Innis B.L., Nimmannitya S., Suntayakorn S., Endy T.P., Raengsakulrach B., Rothman A.L., Ennis F.A., Nisalak A. Dengue viremia titer, antibody response pattern, and virus serotype correlate with disease severity. J. Infect. Dis. 2000, 181(1):2-9.
78. Vu T.T., Holmes E.C., Duong V., Nguyen T.Q., Tran T.H., Quail M., Churcher C., Parkhill J., Cardosa J., Farrar J., Wills B., Lennon N.J., Birren B.W., Buchy P., Henn M.R., Simmons C.P. Emergence of the Asian 1 genotype of dengue virus serotype 2 in Vietnam: in vivo fitness advantage and lineage replacement in South-East Asia. PLoS Negl. Trop. Dis. 2010, 4(7):e757.
79. Wallis T.P., Huang C.Y., Nimkar S.B., Young P.R., Gorman J.J. Determination of the disulfide bond arrangement of dengue virus NS1 protein. J Biol Chem. 2004, 279(20):20729-20741.
80. Weaver S.C., Vasilakis N. Molecular evolution of dengue viruses: contributions of phylogenetics to understanding the history and epidemiology of the preeminent arboviral disease. Infect. Genet. Evol. 2009, 9(4):523-540.
81. WHO (1997). Dengue haemorrhagic fever: diagnosis, treatment, prevention and control. 2nd ed. WHO, Geneva.
82. WHO/TDR (2009). Dengue guidelines for diagnosis, treatment, prevention and control. New Edition. WHO Press, Geneva.
83. Zhao R., Chinnawirotpisan P., Klungthong C., Zhang C., Putnak R. Evidence for inter- and intra-genotypic variations in dengue serotype 4 viruses representing predominant and non-predominant genotypes co-circulating in Thailand from 1977 to 2001. Virus Genes 2010, 41(1):5-13.